Hepatosplenic T-cell lymphoma in an adolescent patient after immunomodulator and biologic therapy for Crohn disease

J Pediatr Gastroenterol Nutr. 2005 Feb;40(2):220-2. doi: 10.1097/00005176-200502000-00026.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use
  • Crohn Disease / complications*
  • Crohn Disease / drug therapy
  • Fatal Outcome
  • Female
  • Gastrointestinal Agents / adverse effects
  • Gastrointestinal Agents / therapeutic use
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use
  • Infliximab
  • Liver Neoplasms / diagnosis
  • Liver Neoplasms / etiology*
  • Lymphoma, T-Cell / diagnosis
  • Lymphoma, T-Cell / etiology*
  • Mercaptopurine / adverse effects*
  • Mercaptopurine / therapeutic use
  • Splenic Neoplasms / diagnosis
  • Splenic Neoplasms / etiology*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Antibodies, Monoclonal
  • Gastrointestinal Agents
  • Immunosuppressive Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab
  • Mercaptopurine